Background High medicine prices contribute to increasing cost of healthcare worldwide.
Many patients with limited resources in sub-Saharan Africa (SSA) are confronted with out-of …

Background Regulating pharmaceutical markets have become a key strategy by most
governments in ensuring the availability and accessibility of quality medicines to its citizens …

Cardiovascular disease (CVD) is a global health threat associated with several risk factors,
including systemic hypertension. Persistent elevation in blood pressure exerts significant …

Background: Implementing medicines pricing policy effectively is important for ensuring
equitable access to essential medicines and ultimately achieving universal health coverage …

South Africa has instituted various mechanisms to render the pricing of pharmaceuticals
more transparent, including the Single Exit Price (SEP) that clarifies the price at which a …

Objectives To compare supplier prices for local tendering and global outsourcing supply
chain systems that are used to purchase pharmaceutical products by the Ministry of Health …

Recent investigations by the Competition Commission of South Africa (SA) of suspected
excessive pricing of cancer medicines in SA by three global pharmaceutical companies …

Background With the goal of improving the affordability of medicines, governments across
the globe have instituted various forms of price controls. Since 2013, India has been …

Abstract Background The South African pharmaceutical market, like many other low-and
middle-income countries, has long been synonymous with high medicine prices. In …

Data collected by the Pan-African Society of Cardiology for the World Heart Federation's
Cardiovascular Diseases Scorecard project in Africa are presented. We summarise the …